RCT shows PES enables decannulation of patients

October 2015

In a pilot study conducted in Münster PES enhanced remission of dysphagia as assessed with fiberoptic endoscopic evaluation of swallowing (FEES), thereby enabling decannulation in 75% of patients.

This trial is published in Intensive Care Medicine Journal read more.

Posted in Clinical | Comments Off on RCT shows PES enables decannulation of patients

Healthy Volunteers needed for new products testing

September 2015

We are looking for healthy people interested in doing research to help us test our new devices for comfort and tolerability before we seek CE mark and launch them commercially.

The study will involve a single 3-hour visit to our research unit where you will be asked to swallow a tube (our new naso-gastric treatment tube) and having some pictures and video recorded of the tube in place.

We are a Manchester based medical device company that have developed a treatment for unsafe swallowing (neurogenic dysphagia) for people with brain injuries such as stroke or diseases such as Parkinson’s. Our treatment stimulates nerves in the throat to trigger the brain’s own repair systems so that swallowing can once again be safe.

For further information please contact:

0161-820-4525           š AHE04@phagenesis.com

Volunteers will be reimbursed for time and inconvenience.

Update: The recruitment for the Healthy Volunteer Study has finished.

Posted in news | Comments Off on Healthy Volunteers needed for new products testing

ESSD support World Swallowing Day to increase awareness of dysphagia

December 2014

World Swallowing Day is 12 December.

To increase awareness about dysphagia, the European Society for Swallowing Disorders (ESSD) has created a short survey  for health care professionals working in dysphagia. Click on the link:  https://www.surveymonkey.com/s/WorldSwallowingDay and fill in the information about the patients you have screened or assessed for dysphagia during the week 8-12 December, the type of patient and tool used and whether you used the ICD code in the medical report.

All participants will be recognized on the ESSD website for collaborating in the survey and will receive the results which we hope will collect valuable information from all over the world.

Please join us in this initiative to increase awareness of dysphagia.

Update: Thank you very much for your contribution to this project! You can see the results following this link: http://www.myessd.org/wsd.php.

 

PHADER Registry now open to clinics

December 2014

PHAryngeal electrical stimulation for treatment of neurogenic Dysphagia: a European Registry (PHADER).

This observational, prospective, post-market follow-up clinical study is designed to enable Phagenesis to demonstrate the real world clinical outcome of Pharyngeal Electrical Stimulation (PES) for the treatment of dysphagia resulting from different neurogenic disorders.

If you are a healthcare professional interested in being part of PHADER please contact us.

For further information see CIP Synopsis PHADER.

From Apprentice to Administration and Finance Officer in just one year

August 2014

MANCHESTER apprentice Johnathon Kynaston has been appointed to administration and finance officer of city based company Phagenesis just one year after starting work at the company.

The 17-year-old has secured this new permanent position following a successful apprenticeship placement by national training provider Positive Outcomes, which specialises in work-based training and apprenticeships. Johnathon is now responsible for a range of areas within the company, handling both office and clinical sectors of the business.

Positive Outcomes training advisor Melissa Cribben worked with Johnathon throughout his training.

She said: “With changes in the age of school leavers, I can see only further growth for apprenticeships. Johnathon is a great example of how beneficial apprentices can be to employers and to those taking them.

“I gave Johnathon the confidence to complete the work and supported him throughout, all the rest he did himself.”

Talking about his time with Phagenesis, Johnathon said he enjoyed working for the company.

He said: “I joined the company nearly a year ago now, but it does not feel like a year at all – I’ve learnt lots of new things and thoroughly enjoyed it in the process. I’m just thrilled that I am now a fully-fledged member of the team, and I cannot wait to continue progressing in my career with Phagenesis.

The apprenticeship was a fantastic opportunity and one that I have benefited greatly from. My advice to others is to seriously consider an apprenticeship – they’re extremely useful as you can learn just as much as you could at college yet you’re gaining work-experience and applying the skills learnt within a work environment.

Johnathon’s trainee officer at Phagenesis Caroline Clayton, who started out as an apprentice herself,  worked alongside Johnathon every step of the way – she said: “Johnathon joined Phagenesis straight from school with very little work experience and immediately took on a number of specific responsibilities such as IT, office and clinical administration. He immediately became a highly valued member of the team and we have all been impressed by his development over the past year. I would wholeheartedly recommend Positive Outcomes and the apprenticeship programme. I personally think that apprenticeships are a great way into the working world.”

Positive Outcomes’ chief executive officer, Chris Longmate, added: “Johnathon is a brilliant example of what can be achieved once enrolled onto a Positive Outcomes apprenticeship. We are all very proud of his success and can’t wait to see how he develops on from here. Apprenticeships are working and Johnathon proves that.”

Johnathon started his apprenticeship just two weeks after completing his GSCE’s at the Droylsden Academy. His progression and training highlight the impact which apprenticeship schemes are having in Manchester and across the country.